4D7-24248-95918
3 vaccinations
2 coded responses
24 check-ins
2 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 481 / MI
- Registered
- 2020-12-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-24
Registered in v-safe
-
2020-12-24
Dose 1 — Pfizer-BioNTech
-
2020-12-24
Survey response — day 0, dose 1MedDRA: Dizziness — Feeling: Fair · Site: Pain · Fatigue or tiredness, NauseaFree text: DizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-25
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2020-12-26
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2020-12-26
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
- 2020-12-27
- 2020-12-28
- 2020-12-29
-
2020-12-30
Health check-in — days 1–6 daily, dose 1Feeling: Good · Muscle or body aches · Be unable to do your normal daily activitiesAdult check-in
-
2020-12-30
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
- 2020-12-31
- 2021-01-07
-
2021-01-14
Dose 2 — Pfizer-BioNTech
-
2021-01-16
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Itching · Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-01-17
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Nausea, Abdominal painAdult check-in
-
2021-01-18
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Redness, Swelling, Itching · Muscle or body achesAdult check-in
-
2021-01-19
Health check-in — days 1–6 daily, dose 2Feeling: Good · Chills, Headache, Muscle or body achesAdult check-in
-
2021-01-21
Health check-in — day 7, dose 2Feeling: Fair · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-28
- 2021-02-04
- 2021-02-12
- 2021-02-18
- 2021-02-25
- 2021-04-15
- 2021-07-17
-
2021-11-11
Dose 3 — Pfizer-BioNTech
- 2022-01-14
- 2022-05-12
-
2022-11-11
Survey response — 12 months, dose 3MedDRA: Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
-
2022-11-11
Report sent to call center — 12 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-11-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-24 | Pfizer-BioNTech | |
| 2 | 2021-01-14 | Pfizer-BioNTech | |
| 3 | 2021-11-11 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2020-12-26 | priority 2/3 | |
| 2020-12-30 | priority 2/3 | |
| 2022-11-11 | Unsuccessful |
Free text
Release 1 — day 0, dose 1
Systemic reaction (other): Dizziness
Release 12 — 12 months, dose 3
Symptoms: Pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Pregnancy | · | · | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release